Answer from: Radiation Oncologist at Academic Institution
In my opinion, this should not be done outside of an IRB-approved research study. We are beginning to see some published experience with moderate hypofractionation in post-prostatectomy patients, which would indicate, at least preliminarily, that this approach may be safe, although the optimal dose ...